Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05367479 · ClinicalTrials.gov registry record · Phase 1

Antibiotics, Gastric Bypass, and the Microbiome

A Phase 1 study, sponsored by Medical College of Wisconsin.

Completed
Registry status
Phase 1
Development phase
23
Enrollment target

NCT05367479 is a Phase 1 study that has completed, run by Medical College of Wisconsin. The registered enrollment target is 23 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05367479, a Phase 1 study, has completed, sponsored by Medical College of Wisconsin.

COMPLETED
Registry status
Phase 1
Development phase
23 participants
Enrollment target

Study Summary

This study randomizes patients to two commonly used peri-procedural antibiotics after gastric bypass with the pre and post-operative collection of stool samples, to identify significant differences in relative abundances of gut microbiota phyla, genera and species between the two antibiotic groups used. Gastric bypass may beneficially affect hypertension by altering the post-operative microbiome and specific antibiotics can further enhance the resolution rate by improving microbial diversity and richness.

Interventions

  • DRUG Antibiotic

Trial Details

FieldValue
Enrollment Target 23 participants
Start Date 2018-07-18
Est. Completion 2020-01-09
Phase Phase 1

Sponsor

Medical College of Wisconsin

447 total trials

What the Registry Record Tells You About NCT05367479

The ClinicalTrials.gov registry entry for NCT05367479 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical College of Wisconsin, which has 447 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Antibiotic is the first listed.

NCT05367479 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05367479 about?

NCT05367479 is a clinical study titled "Antibiotics, Gastric Bypass, and the Microbiome". This study randomizes patients to two commonly used peri-procedural antibiotics after gastric bypass with the pre and post-operative collection of stool samples, to identify significant differences in relative abundances of gut microbiota phyla, genera and species between the two antibiotic groups u...

What is the current status of trial NCT05367479?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 23 participants. The study started on 2018-07-18. Estimated completion is 2020-01-09.

What interventions are being tested in trial NCT05367479?

The interventions under investigation include: Antibiotic (DRUG).

Who is sponsoring clinical trial NCT05367479?

This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.